{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T06:16:38Z","timestamp":1778134598927,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012336","name":"Major State Basic Research Development Program of China","doi-asserted-by":"publisher","award":["2010CB529106"],"award-info":[{"award-number":["2010CB529106"]}],"id":[{"id":"10.13039\/501100012336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.biomaterials.2012.07.047","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T03:01:39Z","timestamp":1344481299000},"page":"8177-8185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutic role of a vaccine targeting RANKL and TNF-\u03b1 on collagen-induced arthritis"],"prefix":"10.1016","volume":"33","author":[{"given":"Huihui","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xulong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shentao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2012.07.047_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.berh.2010.10.001","article-title":"Rheumatoid arthritis","volume":"24","author":"Carmona","year":"2010","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrrheum.2012.23","article-title":"The pathogenesis of rheumatoid arthritis: new insights from old clinical data?","volume":"8","author":"Smolen","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/978-1-4615-0171-8_11","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis and collagen-induced arthritis","volume":"520","author":"Lubberts","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molmed.2008.04.001","article-title":"Molecular mechanisms of inflammatory bone damage: emerging targets for therapy","volume":"14","author":"Herman","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/08916930109014698","article-title":"Rheumatoid arthritis and tumor necrosis factor alpha","volume":"34","author":"Abe","year":"2001","journal-title":"Autoimmunity"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The molecular understanding of osteoclast differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1136\/ard.2009.121764","article-title":"Baseline RANKL: OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis","volume":"69","author":"van Tuyl","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tem.2008.10.007","article-title":"Role of RANKL in bone diseases","volume":"20","author":"Anandarajah","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1476-5381.2010.01099.x","article-title":"Treatment of rheumatoid arthritis with tumour necrosis factor inhibitors","volume":"162","author":"Mewar","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib10","doi-asserted-by":"crossref","first-page":"25190","DOI":"10.1074\/jbc.272.40.25190","article-title":"TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells","volume":"272","author":"Wong","year":"1997","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/jbc.M707933200","article-title":"Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist","volume":"283","author":"Shibata","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib12","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1073\/pnas.1011686107","article-title":"Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis","volume":"107","author":"Ta","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.odw.2008.04.003","article-title":"Augmentation of TNF-induced osteoclast differentiation by inhibition of ERK and activation of p38: similar intracellular signaling between RANKL- and TNF-induced osteoclast differentiation","volume":"67","author":"Inami","year":"2008","journal-title":"Orthod Waves"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib15","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib16","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib17","doi-asserted-by":"crossref","first-page":"R187","DOI":"10.1186\/ar2879","article-title":"RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies","volume":"11","author":"Stolina","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.21021","article-title":"Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models","volume":"52","author":"Schett","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/s10165-008-0131-3","article-title":"Comparison of anti-rheumatic effects of local RNAi-based therapy in collagen induced arthritis rats using various cytokine genes as molecular targets","volume":"19","author":"Inoue","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0264-410X(97)00186-2","article-title":"Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in\u00a0vivo","volume":"15","author":"del Guercio","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0192-0561(97)00069-6","article-title":"Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in\u00a0vivo and in\u00a0vitro","volume":"19","author":"Mittenbuhler","year":"1997","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib22","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-003-0127-1","article-title":"Immunopathogenesis of collagen arthritis","volume":"25","author":"Brand","year":"2003","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1006\/prep.2000.1278","article-title":"Expression, purification, and characterization of the human receptor activator of NF-kappaB ligand (RANKL) extracellular domain","volume":"20","author":"Willard","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pep.2005.02.003","article-title":"Purification, properties, and crystallization of saccharomyces cerevisiae dihydropterin pyrophosphokinase-dihydropteroate synthase","volume":"41","author":"Berglez","year":"2005","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib26","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/10878","article-title":"Therapeutic antibodies elicited by immunization against TNF-alpha","volume":"17","author":"Dalum","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib27","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/cyto.1998.0492","article-title":"Modes of L929 cell death induced by TNF-alpha and other cytotoxic agents","volume":"11","author":"Humphreys","year":"1999","journal-title":"Cytokine"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib28","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1124\/jpet.109.159517","article-title":"Effect of tumor necrosis factor-related apoptosis-inducing ligand on the reduction of joint inflammation in experimental rheumatoid arthritis","volume":"332","author":"Jin","year":"2010","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jim.2010.12.015","article-title":"Flow cytometric mast cell-mediated cytotoxicity assay: a three-color flow cytometric approach using monoclonal antibody staining with annexin V\/propidium iodide co-labeling to assess human mast cell-mediated cytotoxicity by fluorosphere-adjusted counts","volume":"365","author":"Ozdemir","year":"2011","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib30","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib31","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0092-8674(87)90028-6","article-title":"Tumors secreting human TNF\/cachectin induce cachexia in mice","volume":"50","author":"Oliff","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jim.2009.06.009","article-title":"Use of biofluorescence imaging to compare the distribution of certolizumab pegol, adalimumab, and infliximab in the inflamed paws of mice with collagen-induced arthritis","volume":"348","author":"Palframan","year":"2009","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejphar.2010.07.006","article-title":"Nimesulide improves the disease modifying anti-rheumatic profile of methotrexate in mice with collagen-induced arthritis","volume":"644","author":"Al-Abd","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib34","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1096\/fj.04-3556com","article-title":"Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis","volume":"19","author":"Cuzzocrea","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.archoralbio.2011.08.002","article-title":"Immunohistochemical analysis of bone resorption regulators (RANKL and OPG), angiogenic index, and myofibroblasts in syndrome and non-syndrome odontogenic keratocysts","volume":"57","author":"Nonaka","year":"2012","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.02.003","article-title":"Anti-cytokine vaccination: a new biotherapy of autoimmunity?","author":"Semerano","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1398-9995.2010.02462.x","article-title":"Vaccination of adults with asthma and COPD","volume":"66","author":"Pesek","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib39","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/14712591003796546","article-title":"DNA vaccines for transplantation","volume":"10","author":"Li","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrd1284","article-title":"Therapeutic vaccination for chronic diseases: a new class of drugs in sight","volume":"3","author":"Bachmann","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib41","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib42","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1056\/NEJMc062500","article-title":"Tumor necrosis factor inhibitors for rheumatoid arthritis","volume":"355","author":"Roos","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1210\/me.2007-0465","article-title":"Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activation","volume":"23","author":"Cheng","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib44","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbrc.2007.04.058","article-title":"RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways","volume":"357","author":"Nakao","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/art.11487","article-title":"Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction","volume":"50","author":"Zwerina","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib46","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bone.2004.07.004","article-title":"TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis","volume":"35","author":"Saidenberg-Kermanac'h","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.biomaterials.2012.07.047_bib47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2011.04.001","article-title":"Denosumab, a fully human RANKL antibody, reduced bone turnover markers and increased trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys","volume":"49","author":"Ominsky","year":"2011","journal-title":"Bone"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961212008423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961212008423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:44:03Z","timestamp":1758901443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961212008423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":47,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0142961212008423"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.047","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic role of a vaccine targeting RANKL and TNF-\u03b1 on collagen-induced arthritis","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2012.07.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}